SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
NOVEMBER 17, 2003
DATE OF REPORT
(DATE OF EARLIEST EVENT REPORTED)
NEW BRUNSWICK SCIENTIFIC CO., INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)
NEW JERSEY 0-6994 22-1630072
(STATE OR OTHER JURISDICTION OF (COMMISSION FILE NUMBER)
(IRS EMPLOYER IDENTIFICATION NO.)
INCORPORATION)
44 TALMADGE ROAD, EDISON, NJ 08818-4005
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (732) 287-1200
(FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT)
ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS.
THE FOLLOWING INFORMATION IS FURNISHED PURSUANT TO ITEM 2 "ACQUISITION OR
DISPOSITION OF ASSETS":
ON NOVEMBER 17, 2003, NEW BRUNSWICK SCIENTIFIC CO., INC. ISSUED A PRESS
RELEASE
REPORTING ITS ACQUISITION OF RS BIOTECH LTD. THE PRESS RELEASE IS ATTACHED
HERETO AS EXHIBIT 99.1.
EXHIBIT DESCRIPTION
99.1 PRESS RELEASE ISSUED NOVEMBER 17, 2003
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE
REGISTRANT HAD DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE
UNDERSIGNED HEREUNTO DULY AUTHORIZED.
NEW BRUNSWICK SCIENTIFIC CO., INC.
DATE: NOVEMBER 17, 2003 BY: /S/SAMUEL EICHENBAUM
SAMUEL EICHENBAUM
VICE PRESIDENT, FINANCE AND
CHIEF FINANCIAL OFFICER